AMENDMENT NO. 1 TO ASSET RETURN AND TERMINATION AGREEMENTAsset Return and Termination Agreement • May 5th, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This AMENDMENT NO. 1 TO ASSET RETURN AND TERMINATION AGREEMENT (this “Amendment”), effective as of March 20, 2017, amends that certain Asset Return and Termination Agreement, effective December 31, 2016 (the “AR&T Agreement”), by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”), Baxalta Incorporated, a Delaware corporation (“BI”), Baxalta US Inc., a Delaware corporation (“BUSI”), and Baxalta GmbH, a Swiss corporation (“BGMBH” and, together with BI and BUSI, collectively, “Baxalta”). Capitalized terms used herein, but otherwise not defined, shall have the meaning ascribed to them in the AR & T Agreement.
ASSET RETURN AND TERMINATION AGREEMENTAsset Return and Termination Agreement • October 24th, 2016 • Cti Biopharma Corp • Pharmaceutical preparations • New York
This Asset Return and Termination Agreement (this “Agreement”), effective as of October 21, 2016 (the “Effective Date”), is made by and between Baxalta Incorporated, a Delaware corporation (“BI”), Baxalta US Inc., a Delaware corporation (“BUSI”), Baxalta GmbH, a Swiss corporation (“BGMBH” and, together with BI and BUSI, collectively, “Baxalta”), and CTI BioPharma Corp. (f/k/a Cell Therapeutics, Inc.), a corporation organized and existing under the laws of the State of Washington (“CTI”). Baxalta and CTI are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
ASSET RETURN AND TERMINATION AGREEMENTAsset Return and Termination Agreement • February 24th, 2017 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
This Asset Return and Termination Agreement (this “Agreement”), effective as of December 31, 2016 (the “Effective Date”), is made by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”), Baxalta Incorporated, a Delaware corporation (“BI”), Baxalta US Inc., a Delaware corporation (“BUSI”), and Baxalta GmbH, a Swiss corporation (“BGMBH” and, together with BI and BUSI, collectively, “Baxalta”). Momenta and Baxalta are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
